Paper Detail
C
IF
Specific inhibition of p110a subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers. Oncotarget 7: 68546-68558, 2016.  [Article] 
 
Send Email
From
To
Subject